Blue Crest Capital Management LTD Regeneron Pharmaceuticals, Inc. Transaction History

Blue Crest Capital Management LTD

  • $3.2 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $294,291 - $358,857
425 New
425 $349,000
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $910,072 - $1.09 Million
-2,710 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $951,589 - $1.11 Million
2,710 New
2,710 $1.1 Million

Others Institutions Holding REGN

# of Institutions
1,493
Shares Held
85.8M
Call Options Held
1.53M
Put Options Held
1.44M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email